These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2475454)

  • 1. Activity of FCE 20696, a new synthetic immunomodulator, in models of viral and bacterial pathology.
    Verini MA; Ungheri D
    Immunopharmacology; 1989; 17(3):157-65. PubMed ID: 2475454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the new immunoactive compound FCE 20696 on rat and murine models of autoimmune diseases.
    Isetta AM; Ferrari M; Fornasiero MC; Trizio D
    Immunopharmacol Immunotoxicol; 1991; 13(4):499-511. PubMed ID: 1774434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Corynebacterium granulosum-derived P40 immunomodulator exerts a synergistic effect on the activity of antiviral drugs in the treatment of experimental viral infections.
    Fattal-German M; Bizzini B
    Biomed Pharmacother; 1988; 42(3):217-20. PubMed ID: 3179407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antiviral activity of peptide immunomodulator "Gepon" in experimental infections caused by herpes simplex viruses types 1 and 2].
    Barinskiĭ IF; Alimbarova LM; Lazarenko AA; Ataullakhanov RI
    Vopr Virusol; 2003; 48(5):30-3. PubMed ID: 14598478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.
    Ohnishi H; Kosuzume H; Inaba H; Ohkura M; Shimada S; Suzuki Y
    Int J Immunopharmacol; 1983; 5(3):181-96. PubMed ID: 6194125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the anti-viral effect of a short-term oral treatment of mice with live Saccharomyces cerevisiae cells.
    Fattal-German M; Bizzini B
    Dev Biol Stand; 1992; 77():115-20. PubMed ID: 1426651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiviral and anti-stress activity of the gamma-L-glutamyl-histamine and its derivatives].
    Nosik NN; Nebol'sin VE; Zheltukhina GA; Evstigneeva RP; Kondrashina NG; Lavrukhina LA; Krzhechkovskaia VV
    Vopr Virusol; 2003; 48(1):38-42. PubMed ID: 12608061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the interferonogenic and antiviral activity of biologically active substances].
    Kremerman IB; Priĭmiagi LS; Ershov FI
    Vopr Virusol; 1984; 29(5):549-53. PubMed ID: 6083669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiviral effects of pidotimod.
    Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
    Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen specific, suppressor cells induced by the immunomodulator FCE 20696 in aged NZB/WF1 mice.
    Fornasiero MC; Isetta AM; Ferrari M; Trizio D
    Agents Actions; 1986 Dec; 19(5-6):315-7. PubMed ID: 2950736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A).
    Sidwell RW; Huffman JH; Call EW; Warren RP; Radov LA; Murray RJ
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1130-4. PubMed ID: 2821891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tilorone hydrochloride: an orally active antiviral agent.
    Krueger RE; Mayer GD
    Science; 1970 Sep; 169(3951):1213-4. PubMed ID: 4317923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of an immunomodulator, RU 41740, on experimental infections].
    Joly V
    Presse Med; 1988 Jul; 17(28):1430-2. PubMed ID: 2971180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of interferon in experimental viral diseases].
    German A; Quero AM
    Bull Acad Natl Med; 1983 Feb; 167(2):163-9. PubMed ID: 6196097
    [No Abstract]   [Full Text] [Related]  

  • 16. Macrophage activation and host augmentation against Sendai or herpes simplex virus (HSV) infections with synthetic polypeptides in mice.
    Iida J; Nishi N; Saiki I; Mizukoshi N; Ishihara C; Tokura S; Azuma I
    Int J Immunopharmacol; 1989; 11(3):249-58. PubMed ID: 2544534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of oseltamivir and ribavirin used alone and in combination against infections in mice with recent isolates of influenza A (H1N1) and B viruses.
    Smee DF; Wong MH; Bailey KW; Sidwell RW
    Antivir Chem Chemother; 2006; 17(4):185-92. PubMed ID: 17066897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral effect of keishi-ni-eppi-ichi-to, a traditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice.
    Ball MA; Utsunomiya T; Ikemoto K; Kobayashi M; Pollard RB; Suzuki F
    Experientia; 1994 Aug; 50(8):774-9. PubMed ID: 7520870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of host resistance against virus infections by MTP-PE, a synthetic lipophilic muramyl peptide--I. Increased survival in mice and guinea pigs after single drug administration prior to infection, and the effect of MTP-PE on interferon levels in sera and lungs.
    Dietrich FM; Hochkeppel HK; Lukas B
    Int J Immunopharmacol; 1986; 8(8):931-42. PubMed ID: 2433236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.